APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Becker Muscular Dystrophy Drug

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Becker Muscular Dystrophy Drug Industry Growth and Trends Forecast to 2032

Report ID 173969500119 December 202590 pages

Choose your research edition.

Industry ResearchBecker Muscular Dystrophy Drug Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Becker Muscular Dystrophy Drug Industry Growth and Trends Forecast to 203290 pages · $3,450 USDMarket StructureGlobal Becker Muscular Dystrophy Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032186 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Becker Muscular Dystrophy Drug Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Becker Muscular Dystrophy Drug Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Becker Muscular Dystrophy Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Becker Muscular Dystrophy Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Becker Muscular Dystrophy Drug is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Becker Muscular Dystrophy Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Becker Muscular Dystrophy Drug include Sarepta Therapeutics Inc, ReveraGen BioPharma Inc, PTC Therapeutics Inc, Milo Biotechnology LLC and Italfarmaco SpA, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Becker Muscular Dystrophy Drug market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Becker Muscular Dystrophy Drug market size, estimates, and forecasts are presented in terms of sales volume (W Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Becker Muscular Dystrophy Drug market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Becker Muscular Dystrophy Drug.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Becker Muscular Dystrophy Drug market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Becker Muscular Dystrophy Drug Market by Company

Sarepta Therapeutics Inc

ReveraGen BioPharma Inc

PTC Therapeutics Inc

Milo Biotechnology LLC

Italfarmaco SpA

Becker Muscular Dystrophy Drug Segment by Type

ARM-210

Ataluren

Givinostat

Epicatechin

Others

Becker Muscular Dystrophy Drug Segment by Application

Hospital

Clinic

Others

Becker Muscular Dystrophy Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Becker Muscular Dystrophy Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Becker Muscular Dystrophy Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Becker Muscular Dystrophy Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Becker Muscular Dystrophy Drug manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Becker Muscular Dystrophy Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of ARM-210 Table 2. Major Company of Ataluren Table 3. Major Company of Givinostat Table 4. Major Company of Epicatechin Table 5. Major Company of Others Table 6. Global Becker Muscular Dystrophy Drug Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Becker Muscular Dystrophy Drug Sales by Type (2021-2026) & (W Units) Table 8. Global Becker Muscular Dystrophy Drug Sales Market Share in Volume by Type (2021-2026) Table 9. Global Becker Muscular Dystrophy Drug Sales by Type (2021-2026) & (US$ Million) Table 10. Global Becker Muscular Dystrophy Drug Sales Market Share in Value by Type (2021-2026) Table 11. Global Becker Muscular Dystrophy Drug Price by Type (2021-2026) & (US$/Unit) Table 12. Global Becker Muscular Dystrophy Drug Sales by Type (2027-2032) & (W Units) Table 13. Global Becker Muscular Dystrophy Drug Sales Market Share in Volume by Type (2027-2032) Table 14. Global Becker Muscular Dystrophy Drug Sales by Type (2027-2032) & (US$ Million) Table 15. Global Becker Muscular Dystrophy Drug Sales Market Share in Value by Type (2027-2032) Table 16. Global Becker Muscular Dystrophy Drug Price by Type (2027-2032) & (US$/Unit) Table 17. North America Becker Muscular Dystrophy Drug Sales by Type (2021-2026) & (W Units) Table 18. North America Becker Muscular Dystrophy Drug Sales by Type (2021-2026) & (US$ Million) Table 19. Europe Becker Muscular Dystrophy Drug Sales by Type (2021-2026) & (W Units) Table 20. Europe Becker Muscular Dystrophy Drug Sales by Type (2021-2026) & (US$ Million) Table 21. Asia-Pacific Becker Muscular Dystrophy Drug Sales by Type (2021-2026) & (W Units) Table 22. Asia-Pacific Becker Muscular Dystrophy Drug Sales by Type (2021-2026) & (US$ Million) Table 23. Latin America Becker Muscular Dystrophy Drug Sales by Type (2021-2026) & (W Units) Table 24. Latin America Becker Muscular Dystrophy Drug Sales by Type (2021-2026) & (US$ Million) Table 25. Middle East and Africa Becker Muscular Dystrophy Drug Sales by Type (2021-2026) & (W Units) Table 26. Middle East and Africa Becker Muscular Dystrophy Drug Sales by Type (2021-2026) & (US$ Million) Table 27. Becker Muscular Dystrophy Drug Industry Trends Table 28. Becker Muscular Dystrophy Drug Industry Drivers Table 29. Becker Muscular Dystrophy Drug Industry Opportunities and Challenges Table 30. Becker Muscular Dystrophy Drug Industry Restraints Table 31. Global Becker Muscular Dystrophy Drug Sales Revenue by Company (US$ Million) & (2021-2026) Table 32. Global Becker Muscular Dystrophy Drug Revenue Market Share by Company (2021-2026) Table 33. Global Becker Muscular Dystrophy Drug Sales by Company (2021-2026) & (W Units) Table 34. Global Becker Muscular Dystrophy Drug Sales Share by Company (2021-2026) Table 35. Global Becker Muscular Dystrophy Drug Market Price by Company (2021-2026) & (US$/Unit) Table 36. Global Becker Muscular Dystrophy Drug Industry Company Ranking, 2024 VS 2025 VS 2026 Table 37. Global Becker Muscular Dystrophy Drug Major Company Production Sites and Headquarters Table 38. Global Becker Muscular Dystrophy Drug Company, Product Type & Application Table 39. Global Becker Muscular Dystrophy Drug Company Establishment Date Table 40. Global Company Market Concentration Ratio (CR5 and HHI) Table 41. Global Becker Muscular Dystrophy Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 42. Global Becker Muscular Dystrophy Drug Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 43. Global Becker Muscular Dystrophy Drug Sales by Region (2021-2026) & (W Units) Table 44. Global Becker Muscular Dystrophy Drug Sales Market Share in Volume by Region (2021-2026) Table 45. Global Becker Muscular Dystrophy Drug Sales by Region (2021-2026) & (US$ Million) Table 46. Global Becker Muscular Dystrophy Drug Sales Market Share in Value by Region (2021-2026) Table 47. Global Becker Muscular Dystrophy Drug Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 48. Global Becker Muscular Dystrophy Drug Sales by Region (2027-2032) & (W Units) Table 49. Global Becker Muscular Dystrophy Drug Sales Market Share in Volume by Region (2027-2032) Table 50. Global Becker Muscular Dystrophy Drug Sales by Region (2027-2032) & (US$ Million) Table 51. Global Becker Muscular Dystrophy Drug Sales Market Share in Value by Region (2027-2032) Table 52. Global Becker Muscular Dystrophy Drug Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 53. Global Becker Muscular Dystrophy Drug Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 54. Global Becker Muscular Dystrophy Drug Sales by Application (2021-2026) & (W Units) Table 55. Global Becker Muscular Dystrophy Drug Sales Market Share in Volume by Application (2021-2026) Table 56. Global Becker Muscular Dystrophy Drug Sales by Application (2021-2026) & (US$ Million) Table 57. Global Becker Muscular Dystrophy Drug Sales Market Share in Value by Application (2021-2026) Table 58. Global Becker Muscular Dystrophy Drug Price by Application (2021-2026) & (US$/Unit) Table 59. Global Becker Muscular Dystrophy Drug Sales by Application (2027-2032) & (W Units) Table 60. Global Becker Muscular Dystrophy Drug Sales Market Share in Volume by Application (2027-2032) Table 61. Global Becker Muscular Dystrophy Drug Sales by Application (2027-2032) & (US$ Million) Table 62. Global Becker Muscular Dystrophy Drug Sales Market Share in Value by Application (2027-2032) Table 63. Global Becker Muscular Dystrophy Drug Price by Application (2027-2032) & (US$/Unit) Table 64. North America Becker Muscular Dystrophy Drug Sales by Application (2021-2026) & (W Units) Table 65. North America Becker Muscular Dystrophy Drug Sales by Application (2021-2026) & (US$ Million) Table 66. Europe Becker Muscular Dystrophy Drug Sales by Application (2021-2026) & (W Units) Table 67. Europe Becker Muscular Dystrophy Drug Sales by Application (2021-2026) & (US$ Million) Table 68. Asia-Pacific Becker Muscular Dystrophy Drug Sales by Application (2021-2026) & (W Units) Table 69. Asia-Pacific Becker Muscular Dystrophy Drug Sales by Application (2021-2026) & (US$ Million) Table 70. Latin America Becker Muscular Dystrophy Drug Sales by Application (2021-2026) & (W Units) Table 71. Latin America Becker Muscular Dystrophy Drug Sales by Application (2021-2026) & (US$ Million) Table 72. Middle East and Africa Becker Muscular Dystrophy Drug Sales by Application (2021-2026) & (W Units) Table 73. Middle East and Africa Becker Muscular Dystrophy Drug Sales by Application (2021-2026) & (US$ Million) Table 74. Sarepta Therapeutics Inc Company Information Table 75. Sarepta Therapeutics Inc Business Overview Table 76. Sarepta Therapeutics Inc Becker Muscular Dystrophy Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Sarepta Therapeutics Inc Becker Muscular Dystrophy Drug Product Portfolio Table 78. Sarepta Therapeutics Inc Recent Development Table 79. ReveraGen BioPharma Inc Company Information Table 80. ReveraGen BioPharma Inc Business Overview Table 81. ReveraGen BioPharma Inc Becker Muscular Dystrophy Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. ReveraGen BioPharma Inc Becker Muscular Dystrophy Drug Product Portfolio Table 83. ReveraGen BioPharma Inc Recent Development Table 84. PTC Therapeutics Inc Company Information Table 85. PTC Therapeutics Inc Business Overview Table 86. PTC Therapeutics Inc Becker Muscular Dystrophy Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. PTC Therapeutics Inc Becker Muscular Dystrophy Drug Product Portfolio Table 88. PTC Therapeutics Inc Recent Development Table 89. Milo Biotechnology LLC Company Information Table 90. Milo Biotechnology LLC Business Overview Table 91. Milo Biotechnology LLC Becker Muscular Dystrophy Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Milo Biotechnology LLC Becker Muscular Dystrophy Drug Product Portfolio Table 93. Milo Biotechnology LLC Recent Development Table 94. Italfarmaco SpA Company Information Table 95. Italfarmaco SpA Business Overview Table 96. Italfarmaco SpA Becker Muscular Dystrophy Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Italfarmaco SpA Becker Muscular Dystrophy Drug Product Portfolio Table 98. Italfarmaco SpA Recent Development Table 99. North America Becker Muscular Dystrophy Drug Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 100. North America Becker Muscular Dystrophy Drug Sales by Country (2021-2026) & (W Units) Table 101. North America Becker Muscular Dystrophy Drug Sales Market Share by Country (2021-2026) Table 102. North America Becker Muscular Dystrophy Drug Sales Forecast by Country (2027-2032) & (W Units) Table 103. North America Becker Muscular Dystrophy Drug Sales Market Share Forecast by Country (2027-2032) Table 104. North America Becker Muscular Dystrophy Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 105. North America Becker Muscular Dystrophy Drug Market Size by Country (2021-2026) & (US$ Million) Table 106. North America Becker Muscular Dystrophy Drug Market Share by Country (2021-2026) Table 107. North America Becker Muscular Dystrophy Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 108. North America Becker Muscular Dystrophy Drug Market Share Forecast by Country (2027-2032) Table 109. Europe Becker Muscular Dystrophy Drug Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 110. Europe Becker Muscular Dystrophy Drug Sales by Country (2021-2026) & (W Units) Table 111. Europe Becker Muscular Dystrophy Drug Sales Market Share by Country (2021-2026) Table 112. Europe Becker Muscular Dystrophy Drug Sales Forecast by Country (2027-2032) & (W Units) Table 113. Europe Becker Muscular Dystrophy Drug Sales Market Share Forecast by Country (2027-2032) Table 114. Europe Becker Muscular Dystrophy Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 115. Europe Becker Muscular Dystrophy Drug Market Size by Country (2021-2026) & (US$ Million) Table 116. Europe Becker Muscular Dystrophy Drug Market Share by Country (2021-2026) Table 117. Europe Becker Muscular Dystrophy Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 118. Europe Becker Muscular Dystrophy Drug Market Share Forecast by Country (2027-2032) Table 119. Asia-Pacific Becker Muscular Dystrophy Drug Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 120. Asia-Pacific Becker Muscular Dystrophy Drug Sales by Country (2021-2026) & (W Units) Table 121. Asia-Pacific Becker Muscular Dystrophy Drug Sales Market Share by Country (2021-2026) Table 122. Asia-Pacific Becker Muscular Dystrophy Drug Sales Forecast by Country (2027-2032) & (W Units) Table 123. Asia-Pacific Becker Muscular Dystrophy Drug Sales Market Share Forecast by Country (2027-2032) Table 124. Asia-Pacific Becker Muscular Dystrophy Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 125. Asia-Pacific Becker Muscular Dystrophy Drug Market Size by Country (2021-2026) & (US$ Million) Table 126. Asia-Pacific Becker Muscular Dystrophy Drug Market Share by Country (2021-2026) Table 127. Asia-Pacific Becker Muscular Dystrophy Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 128. Asia-Pacific Becker Muscular Dystrophy Drug Market Share Forecast by Country (2027-2032) Table 129. Latin America Becker Muscular Dystrophy Drug Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 130. Latin America Becker Muscular Dystrophy Drug Sales by Country (2021-2026) & (W Units) Table 131. Latin America Becker Muscular Dystrophy Drug Sales Market Share by Country (2021-2026) Table 132. Latin America Becker Muscular Dystrophy Drug Sales Forecast by Country (2027-2032) & (W Units) Table 133. Latin America Becker Muscular Dystrophy Drug Sales Market Share Forecast by Country (2027-2032) Table 134. Latin America Becker Muscular Dystrophy Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 135. Latin America Becker Muscular Dystrophy Drug Market Size by Country (2021-2026) & (US$ Million) Table 136. Latin America Becker Muscular Dystrophy Drug Market Share by Country (2021-2026) Table 137. Latin America Becker Muscular Dystrophy Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 138. Latin America Becker Muscular Dystrophy Drug Market Share Forecast by Country (2027-2032) Table 139. Middle East and Africa Becker Muscular Dystrophy Drug Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 140. Middle East and Africa Becker Muscular Dystrophy Drug Sales by Country (2021-2026) & (W Units) Table 141. Middle East and Africa Becker Muscular Dystrophy Drug Sales Market Share by Country (2021-2026) Table 142. Middle East and Africa Becker Muscular Dystrophy Drug Sales Forecast by Country (2027-2032) & (W Units) Table 143. Middle East and Africa Becker Muscular Dystrophy Drug Sales Market Share Forecast by Country (2027-2032) Table 144. Middle East and Africa Becker Muscular Dystrophy Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 145. Middle East and Africa Becker Muscular Dystrophy Drug Market Size by Country (2021-2026) & (US$ Million) Table 146. Middle East and Africa Becker Muscular Dystrophy Drug Market Share by Country (2021-2026) Table 147. Middle East and Africa Becker Muscular Dystrophy Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 148. Middle East and Africa Becker Muscular Dystrophy Drug Market Share Forecast by Country (2027-2032) Table 149. Key Raw Materials Table 150. Raw Materials Key Suppliers Table 151. Becker Muscular Dystrophy Drug Distributors List Table 152. Becker Muscular Dystrophy Drug Customers List Table 153. Research Programs/Design for This Report Table 154. Authors List of This Report Table 155. Secondary Sources Table 156. Primary Sources List of Figures Figure 1. Becker Muscular Dystrophy Drug Image Figure 2. Global Becker Muscular Dystrophy Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Becker Muscular Dystrophy Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Becker Muscular Dystrophy Drug Sales (2021-2032) & (W Units) Figure 5. ARM-210 Image Figure 6. Global ARM-210 Sales YoY Growth (2021-2032) & (W Units) Figure 7. Ataluren Image Figure 8. Global Ataluren Sales YoY Growth (2021-2032) & (W Units) Figure 9. Givinostat Image Figure 10. Global Givinostat Sales YoY Growth (2021-2032) & (W Units) Figure 11. Epicatechin Image Figure 12. Global Epicatechin Sales YoY Growth (2021-2032) & (W Units) Figure 13. Others Image Figure 14. Global Others Sales YoY Growth (2021-2032) & (W Units) Figure 15. Global Becker Muscular Dystrophy Drug Market Size Overview by Type (2021-2032) & (US$ Million) Figure 16. Global Becker Muscular Dystrophy Drug Market Share by Type 2025 VS 2032 Figure 17. North America Becker Muscular Dystrophy Drug Sales Market Share in Volume by Type in 2025 Figure 18. North America Becker Muscular Dystrophy Drug Sales Market Share in Value by Type in 2025 Figure 19. Europe Becker Muscular Dystrophy Drug Sales Market Share in Volume by Type in 2025 Figure 20. Europe Becker Muscular Dystrophy Drug Sales Market Share in Value by Type in 2025 Figure 21. Asia-Pacific Becker Muscular Dystrophy Drug Sales Market Share in Volume by Type in 2025 Figure 22. Asia-Pacific Becker Muscular Dystrophy Drug Sales Market Share in Value by Type in 2025 Figure 23. Latin America Becker Muscular Dystrophy Drug Sales Market Share in Volume by Type in 2025 Figure 24. Latin America Becker Muscular Dystrophy Drug Sales Market Share in Value by Type in 2025 Figure 25. Middle East and Africa Becker Muscular Dystrophy Drug Sales Market Share in Volume by Type in 2025 Figure 26. Middle East and Africa Becker Muscular Dystrophy Drug Sales Market Share in Value by Type in 2025 Figure 27. Global Top 5 and 10 Becker Muscular Dystrophy Drug Players Market Share by Revenue in 2025 Figure 28. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Hospital Image Figure 30. Global Hospital Sales YoY Growth (2021-2032) & (W Units) Figure 31. Clinic Image Figure 32. Global Clinic Sales YoY Growth (2021-2032) & (W Units) Figure 33. Others Image Figure 34. Global Others Sales YoY Growth (2021-2032) & (W Units) Figure 35. Global Becker Muscular Dystrophy Drug Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Becker Muscular Dystrophy Drug Market Share by Application 2025 VS 2032 Figure 37. North America Becker Muscular Dystrophy Drug Sales Market Share in Volume by Application in 2025 Figure 38. North America Becker Muscular Dystrophy Drug Sales Market Share in Value by Application in 2025 Figure 39. Europe Becker Muscular Dystrophy Drug Sales Market Share in Volume by Application in 2025 Figure 40. Europe Becker Muscular Dystrophy Drug Sales Market Share in Value by Application in 2025 Figure 41. Asia-Pacific Becker Muscular Dystrophy Drug Sales Market Share in Volume by Application in 2025 Figure 42. Asia-Pacific Becker Muscular Dystrophy Drug Sales Market Share in Value by Application in 2025 Figure 43. Latin America Becker Muscular Dystrophy Drug Sales Market Share in Volume by Application in 2025 Figure 44. Latin America Becker Muscular Dystrophy Drug Sales Market Share in Value by Application in 2025 Figure 45. Middle East and Africa Becker Muscular Dystrophy Drug Sales Market Share in Volume by Application in 2025 Figure 46. Middle East and Africa Becker Muscular Dystrophy Drug Sales Market Share in Value by Application in 2025 Figure 47. North America Becker Muscular Dystrophy Drug Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 48. North America Becker Muscular Dystrophy Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. North America Becker Muscular Dystrophy Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. North America Becker Muscular Dystrophy Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Becker Muscular Dystrophy Drug Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 52. Europe Becker Muscular Dystrophy Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Becker Muscular Dystrophy Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Europe Becker Muscular Dystrophy Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Becker Muscular Dystrophy Drug Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 56. Asia-Pacific Becker Muscular Dystrophy Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Becker Muscular Dystrophy Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Asia-Pacific Becker Muscular Dystrophy Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Becker Muscular Dystrophy Drug Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 60. Latin America Becker Muscular Dystrophy Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Becker Muscular Dystrophy Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Latin America Becker Muscular Dystrophy Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Becker Muscular Dystrophy Drug Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 64. Middle East and Africa Becker Muscular Dystrophy Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Becker Muscular Dystrophy Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Middle East and Africa Becker Muscular Dystrophy Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Becker Muscular Dystrophy Drug Value Chain Figure 68. Key Raw Materials Price Figure 69. Manufacturing Cost Structure Figure 70. Becker Muscular Dystrophy Drug Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • ARM-210
  • Ataluren
  • Givinostat
  • Epicatechin
  • Others
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Sarepta Therapeutics Inc
  • ReveraGen BioPharma Inc
  • PTC Therapeutics Inc
  • Milo Biotechnology LLC
  • Italfarmaco SpA

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Becker Muscular Dystrophy Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Becker Muscular Dystrophy Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Becker Muscular Dystrophy Drug Market by Type
  6. 1.3.1 ARM-210
  7. 1.3.2 Ataluren
  8. 1.3.3 Givinostat
  9. 1.3.4 Epicatechin
  10. 1.3.5 Others
  11. 1.4 Global Becker Muscular Dystrophy Drug Market Size by Type
  12. 1.4.1 Global Becker Muscular Dystrophy Drug Market Size Overview by Type (2021-2032)
  13. 1.4.2 Global Becker Muscular Dystrophy Drug Historic Market Size Review by Type (2021-2026)
  14. 1.4.3 Global Becker Muscular Dystrophy Drug Forecasted Market Size by Type (2027-2032)
  15. 1.5 Key Regions Market Size by Type
  16. 1.5.1 North America Becker Muscular Dystrophy Drug Sales Breakdown by Type (2021-2026)
  17. 1.5.2 Europe Becker Muscular Dystrophy Drug Sales Breakdown by Type (2021-2026)
  18. 1.5.3 Asia-Pacific Becker Muscular Dystrophy Drug Sales Breakdown by Type (2021-2026)
  19. 1.5.4 South America Becker Muscular Dystrophy Drug Sales Breakdown by Type (2021-2026)
  20. 1.5.5 Middle East and Africa Becker Muscular Dystrophy Drug Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Becker Muscular Dystrophy Drug Industry Trends
  2. 2.2 Becker Muscular Dystrophy Drug Industry Drivers
  3. 2.3 Becker Muscular Dystrophy Drug Industry Opportunities and Challenges
  4. 2.4 Becker Muscular Dystrophy Drug Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Becker Muscular Dystrophy Drug Revenue (2021-2026)
  2. 3.2 Global Top Players by Becker Muscular Dystrophy Drug Sales (2021-2026)
  3. 3.3 Global Top Players by Becker Muscular Dystrophy Drug Price (2021-2026)
  4. 3.4 Global Becker Muscular Dystrophy Drug Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Becker Muscular Dystrophy Drug Major Company Production Sites & Headquarters
  6. 3.6 Global Becker Muscular Dystrophy Drug Company, Product Type & Application
  7. 3.7 Global Becker Muscular Dystrophy Drug Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Becker Muscular Dystrophy Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Becker Muscular Dystrophy Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Becker Muscular Dystrophy Drug Tier 1, Tier 2, and Tier 3
4 Becker Muscular Dystrophy Drug Regional Status and Outlook
  1. 4.1 Global Becker Muscular Dystrophy Drug Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Becker Muscular Dystrophy Drug Historic Market Size by Region
  3. 4.2.1 Global Becker Muscular Dystrophy Drug Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Becker Muscular Dystrophy Drug Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Becker Muscular Dystrophy Drug Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Becker Muscular Dystrophy Drug Forecasted Market Size by Region
  7. 4.3.1 Global Becker Muscular Dystrophy Drug Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Becker Muscular Dystrophy Drug Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Becker Muscular Dystrophy Drug Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Becker Muscular Dystrophy Drug by Application
  1. 5.1 Becker Muscular Dystrophy Drug Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Others
  5. 5.2 Global Becker Muscular Dystrophy Drug Market Size by Application
  6. 5.2.1 Global Becker Muscular Dystrophy Drug Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Becker Muscular Dystrophy Drug Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Becker Muscular Dystrophy Drug Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Becker Muscular Dystrophy Drug Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Becker Muscular Dystrophy Drug Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Becker Muscular Dystrophy Drug Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Becker Muscular Dystrophy Drug Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Becker Muscular Dystrophy Drug Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Sarepta Therapeutics Inc
  2. 6.1.1 Sarepta Therapeutics Inc Company Information
  3. 6.1.2 Sarepta Therapeutics Inc Business Overview
  4. 6.1.3 Sarepta Therapeutics Inc Becker Muscular Dystrophy Drug Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Sarepta Therapeutics Inc Becker Muscular Dystrophy Drug Product Portfolio
  6. 6.1.5 Sarepta Therapeutics Inc Recent Developments
  7. 6.2 ReveraGen BioPharma Inc
  8. 6.2.1 ReveraGen BioPharma Inc Company Information
  9. 6.2.2 ReveraGen BioPharma Inc Business Overview
  10. 6.2.3 ReveraGen BioPharma Inc Becker Muscular Dystrophy Drug Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 ReveraGen BioPharma Inc Becker Muscular Dystrophy Drug Product Portfolio
  12. 6.2.5 ReveraGen BioPharma Inc Recent Developments
  13. 6.3 PTC Therapeutics Inc
  14. 6.3.1 PTC Therapeutics Inc Company Information
  15. 6.3.2 PTC Therapeutics Inc Business Overview
  16. 6.3.3 PTC Therapeutics Inc Becker Muscular Dystrophy Drug Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 PTC Therapeutics Inc Becker Muscular Dystrophy Drug Product Portfolio
  18. 6.3.5 PTC Therapeutics Inc Recent Developments
  19. 6.4 Milo Biotechnology LLC
  20. 6.4.1 Milo Biotechnology LLC Company Information
  21. 6.4.2 Milo Biotechnology LLC Business Overview
  22. 6.4.3 Milo Biotechnology LLC Becker Muscular Dystrophy Drug Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Milo Biotechnology LLC Becker Muscular Dystrophy Drug Product Portfolio
  24. 6.4.5 Milo Biotechnology LLC Recent Developments
  25. 6.5 Italfarmaco SpA
  26. 6.5.1 Italfarmaco SpA Company Information
  27. 6.5.2 Italfarmaco SpA Business Overview
  28. 6.5.3 Italfarmaco SpA Becker Muscular Dystrophy Drug Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Italfarmaco SpA Becker Muscular Dystrophy Drug Product Portfolio
  30. 6.5.5 Italfarmaco SpA Recent Developments
7 North America by Country
  1. 7.1 North America Becker Muscular Dystrophy Drug Sales by Country
  2. 7.1.1 North America Becker Muscular Dystrophy Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Becker Muscular Dystrophy Drug Sales by Country (2021-2026)
  4. 7.1.3 North America Becker Muscular Dystrophy Drug Sales Forecast by Country (2027-2032)
  5. 7.2 North America Becker Muscular Dystrophy Drug Market Size by Country
  6. 7.2.1 North America Becker Muscular Dystrophy Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Becker Muscular Dystrophy Drug Market Size by Country (2021-2026)
  8. 7.2.3 North America Becker Muscular Dystrophy Drug Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Becker Muscular Dystrophy Drug Sales by Country
  2. 8.1.1 Europe Becker Muscular Dystrophy Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Becker Muscular Dystrophy Drug Sales by Country (2021-2026)
  4. 8.1.3 Europe Becker Muscular Dystrophy Drug Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Becker Muscular Dystrophy Drug Market Size by Country
  6. 8.2.1 Europe Becker Muscular Dystrophy Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Becker Muscular Dystrophy Drug Market Size by Country (2021-2026)
  8. 8.2.3 Europe Becker Muscular Dystrophy Drug Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Becker Muscular Dystrophy Drug Sales by Country
  2. 9.1.1 Asia-Pacific Becker Muscular Dystrophy Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Becker Muscular Dystrophy Drug Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Becker Muscular Dystrophy Drug Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Becker Muscular Dystrophy Drug Market Size by Country
  6. 9.2.1 Asia-Pacific Becker Muscular Dystrophy Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Becker Muscular Dystrophy Drug Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Becker Muscular Dystrophy Drug Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Becker Muscular Dystrophy Drug Sales by Country
  2. 10.1.1 South America Becker Muscular Dystrophy Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Becker Muscular Dystrophy Drug Sales by Country (2021-2026)
  4. 10.1.3 South America Becker Muscular Dystrophy Drug Sales Forecast by Country (2027-2032)
  5. 10.2 South America Becker Muscular Dystrophy Drug Market Size by Country
  6. 10.2.1 South America Becker Muscular Dystrophy Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Becker Muscular Dystrophy Drug Market Size by Country (2021-2026)
  8. 10.2.3 South America Becker Muscular Dystrophy Drug Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Becker Muscular Dystrophy Drug Sales by Country
  2. 11.1.1 Middle East and Africa Becker Muscular Dystrophy Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Becker Muscular Dystrophy Drug Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Becker Muscular Dystrophy Drug Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Becker Muscular Dystrophy Drug Market Size by Country
  6. 11.2.1 Middle East and Africa Becker Muscular Dystrophy Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Becker Muscular Dystrophy Drug Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Becker Muscular Dystrophy Drug Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Becker Muscular Dystrophy Drug Value Chain Analysis
  2. 12.1.1 Becker Muscular Dystrophy Drug Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Becker Muscular Dystrophy Drug Production Mode & Process
  7. 12.2 Becker Muscular Dystrophy Drug Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Becker Muscular Dystrophy Drug Distributors
  10. 12.2.3 Becker Muscular Dystrophy Drug Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst